AGTHX
Price
$74.88
Change
-$9.71 (-11.48%)
Updated
Dec 18 closing price
FBGRX
Price
$228.74
Change
-$8.02 (-3.39%)
Updated
Dec 18 closing price
Ad is loading...

AGTHX vs FBGRX

Header iconAGTHX vs FBGRX Comparison
Open Charts AGTHX vs FBGRXBanner chart's image
American Funds Growth Fund of Amer A
Price$74.88
Change-$9.71 (-11.48%)
VolumeN/A
CapitalizationN/A
Fidelity Blue Chip Growth
Price$228.74
Change-$8.02 (-3.39%)
VolumeN/A
CapitalizationN/A
AGTHX vs FBGRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
AGTHX vs. FBGRX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AGTHX is a Hold and FBGRX is a StrongBuy.

FUNDAMENTALS
Fundamentals
AGTHX has more cash in the bank: 313B vs. FBGRX (72.7B). AGTHX pays higher dividends than FBGRX: AGTHX (0.49) vs FBGRX (0.00). AGTHX was incepted earlier than FBGRX: AGTHX (51 years) vs FBGRX (37 years). AGTHX is a more actively managed with annual turnover of: 31.00 vs. FBGRX (19.00). FBGRX has a lower initial minimum investment than AGTHX: FBGRX (0) vs AGTHX (250). FBGRX annual gain was more profitable for investors over the last year : 36.95 vs. AGTHX (19.24). FBGRX return over 5 years is better than : 121.00 vs. AGTHX (47.96).
AGTHXFBGRXAGTHX / FBGRX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence51 years37 years-
Gain YTD18.99236.92151%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets313B72.7B431%
Annual Yield % from dividends0.490.00-
Returns for 1 year19.2436.9552%
Returns for 3 years5.4233.7416%
Returns for 5 years47.96121.0040%
Returns for 10 years76.15245.4331%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NGL4.810.15
+3.22%
NGL Energy Partners LP
CSPI17.990.51
+2.92%
CSP
ADNT17.60-0.01
-0.06%
Adient plc
FWONA85.52-0.66
-0.77%
Liberty Media Corp
RLMD0.36-0.03
-6.97%
Relmada Therapeutics